Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(19):1444-1445; doi:10.1093/jnci/93.19.1444
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Miller, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 19, 1444-1445, October 3, 2001
© 2001 Oxford University Press

NEWS

Cancer Incidence Trends Differ Between Europe, United States

Mike Miller

In June, the U.S. government reported declines in overall cancer incidence rates for the fourth year in a row. Despite somewhat similar demographics in western European populations, cancer rates there have not followed suit, and instead show an overall increase.

Lynn Ries, Ph.D., of the National Cancer Institute’s Surveillance Research Program, attributes the overall decline to prostate cancer screening. The United States started using prostate-specific antigen to screen for prostate cancer in the late 1980s. This drove up incidence . . . [Full Text of this Article]

Standard Populations

Other Comparison Problems


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?